Legal & General Group’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Legal & General Group’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-9,071	Closed	-$491K	–	3007
2016 Q1	$491K	Buy	9,071 +860	+10%	+$63.5K	﹤0.01%	1319
2015 Q4	$922K	Buy	8,211 +329	+4%	+$36.2K	﹤0.01%	1174
2015 Q3	$916K	Buy	7,882 +1,990	+34%	+$260K	﹤0.01%	1136
2015 Q2	$448K	Buy	5,892 +759	+15%	+$49.8K	﹤0.01%	1358
2015 Q1	$295K	Hold	5,133	–	–	﹤0.01%	1497
2014 Q4	$164K	Hold	5,133	–	–	﹤0.01%	1688
2014 Q3	$128K	Buy	+5,133	New	+$104K	﹤0.01%	1747

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Legal & General Group's ANAC Position: Q2 2016 in Review

Legal & General Group sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 9,071 shares — an estimated $491K sold.

Legal & General Group first reported a position in ANAC in Q3 2014 and held it in 7 quarters. The position peaked at $922K in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Legal & General Group reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Legal & General Group sold 9,071 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $491K.
Legal & General Group first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2014 and held it in 7 quarters.
Legal & General Group's ANACOR PHARMACEUTICALS INC COM position peaked at $922K in Q4 2015.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Legal & General Group's 13F filing for Q2 2016, filed 16 Aug 2016.